What is RxSight, Inc.'s revenue?

RxSight, Inc. (RXST) generated $127.5M in revenue over the trailing twelve months, down 14.1% year over year.

Is RxSight, Inc. profitable?

RxSight, Inc. is not currently profitable: it reported a net loss of $46.6M over the trailing twelve months, a -36.6% net margin.

What are RxSight, Inc.'s profit margins?

Gross margin is 77.0% and operating margin is -43.4%, with a -36.6% net margin.

What is RxSight, Inc.'s earnings per share?

RxSight, Inc.'s diluted EPS over the trailing twelve months is $-1.13.

Where does RxSight, Inc.'s income statement data come from?

Every line is extracted from RxSight, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

RxSight, Inc. RXST Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Total revenue	$134.48M-3.9%	$139.93M+57.1%	$89.08M+81.8%	$49.01M+117%
Total cost of revenue	$31.47M-23.2%	$40.98M+16.1%	$35.31M+27.6%	$27.68M+53.1%
Gross profit	$103.01M+4.1%	$98.94M+84.0%	$53.77M+152%	$21.33M+372%
Gross margin	76.6%+5.9pp	70.7%+10.4pp	60.4%+16.8pp	43.5%+23.5pp
Research and development	$38.55M+12.2%	$34.37M+18.3%	$29.05M+11.8%	$25.98M+6.0%
Selling, general and administrative	$112.65M+11.1%	$101.43M+35.6%	$74.8M+27.5%	$58.67M+78.8%
Total operating expenses	$151.2M+11.3%	$135.8M+30.8%	$103.85M+22.7%	$84.65M+47.7%
Operating income	-$48.19M-30.8%	-$36.86M+26.4%	-$50.09M+20.9%	-$63.32M-19.9%
Operating margin	-35.8%-9.5pp	-26.3%+29.9pp	-56.2%+73.0pp	-129.2%+104pp
Interest expense	$20K-9.1%	$22K-99.3%	$3.31M-33.1%	$4.95M+34.3%
Income before income taxes	-$38.88M-41.9%	-$27.41M+43.6%	-$48.59M+27.2%	-$66.75M-37.1%
Income tax expense	$65K+30.0%	$50K—	——	$9K+12.5%
Net income	-$38.94M-41.8%	-$27.46M+43.5%	-$48.61M+27.2%	-$66.76M-37.1%
Net margin	-29%-9.3pp	-19.6%+34.9pp	-54.6%+81.7pp	-136.2%+79.3pp
Diluted earnings per share	-$0.95-31.9%	-$0.72+49.3%	-$1.42+41.1%	-$2.41—
EBITDA	-$44.93M-35.0%	-$33.28M+27.7%	-$46.01M+22.6%	-$59.43M-21.8%
EBITDA margin	-33.4%-9.6pp	-23.8%+27.9pp	-51.6%+69.6pp	-121.3%+94.8pp
EBIT	-$48.19M-30.8%	-$36.86M+26.4%	-$50.09M+20.9%	-$63.32M-19.9%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about RxSight, Inc..

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is RxSight, Inc.'s revenue?: RxSight, Inc. (RXST) generated $127.5M in revenue over the trailing twelve months, down 14.1% year over year.
Is RxSight, Inc. profitable?: RxSight, Inc. is not currently profitable: it reported a net loss of $46.6M over the trailing twelve months, a -36.6% net margin.
What are RxSight, Inc.'s profit margins?: Gross margin is 77.0% and operating margin is -43.4%, with a -36.6% net margin.
What is RxSight, Inc.'s earnings per share?: RxSight, Inc.'s diluted EPS over the trailing twelve months is $-1.13.
Where does RxSight, Inc.'s income statement data come from?: Every line is extracted from RxSight, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.